| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 150, Issue 1 17-30, Copyright © 1993 by American Association of Immunologists
ARTICLES |
ZK Ballas and W Rasmussen
Iowa City VA Medical Center, IA.
Murine IL-2-induced lymphokine-activated killers (LAK) can be divided into two mutually exclusive subsets: NK1.1+CD8- and NK1.1-CD8+. We have previously established that the lytically active subset of each of these two populations expressed B220, as determined by the mAb 6B2, on its surface. In this study, we examined the lytically active subsets induced by IL-4. We found that, similar to IL-2, the lytically active IL-4-LAK expressed B220 on their surface. Similar to IL-2-LAK, IL-4-LAK cultures also contained NK1.1+CD8- B220+, and NK1.1-CD8+B220+ subsets. IL-4-LAK cultures, however, contained two novel and unexpected lymphocyte subsets determined by their surface markers to be either: i) NK1.1+CD8 alpha+beta-B220+, or ii) NK1.1-CD8 alpha+beta-B220+. These subsets were not derived from NK1.1+ or CD8+ precursors but were induced from a CD4-CD8-NK1.1-Slg- splenocyte subpopulation. Most of the CD8 alpha+beta- cells seen in the IL-4 cultures expressed TCR-alpha beta with little or no TCR-gamma delta detected on their surface. Similar to IL-2-LAK, the IL-4-LAK subsets appeared to display a bias as to their susceptible target cells with the NK1.1-CD8 alpha+beta+ subset being most potent against trinitrophenyl-modified autologous lymphoblasts (2,4,6-trinitrobenzene sulfonic acid (TNBS)-self). The NK1.1+CD8 alpha-beta- effectors were most potent against YAC-1 and CL27A with little activity against TNBS-self. All three targets were susceptible to lysis by the NK1.1+CD8 alpha+beta- subset. These findings document the characteristics of a novel lymphocyte subset, derived from splenic precursors, which shares certain features with cells previously thought to be present exclusively in intraepithelial lymphocytes.
This article has been cited by other articles:
|
|
 |
|
  B. J. Willett, E. L. McMonagle, N. Logan, O. B. Spiller, P. Schneider, and M. J. Hosie Probing the Interaction between Feline Immunodeficiency Virus and CD134 by Using the Novel Monoclonal Antibody 7D6 and the CD134 (Ox40) Ligand J. Virol., September 15, 2007; 81(18): 9665 - 9679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. V. Fostel, J. Dluzniewska, Y. Shimizu, B. J. Burbach, and E. J. Peterson ADAP is dispensable for NK cell development and function Int. Immunol., August 1, 2006; 18(8): 1305 - 1314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C.-F. Hsieh, A. Loukas, A. M. Wahl, M. Bhatia, Y. Wang, A. L. Williamson, K. W. Kehn, H. Maruyama, P. J. Hotez, D. Leitenberg, et al. A Secreted Protein from the Human Hookworm Necator americanus Binds Selectively to NK Cells and Induces IFN-{gamma} Production J. Immunol., August 15, 2004; 173(4): 2699 - 2704. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Chen, J. Zhang, S. A. Moore, Z. K. Ballas, J. P. Portanova, A. M. Krieg, and D. J. Berg CpG DNA induces cyclooxygenase-2 expression and prostaglandin production Int. Immunol., August 1, 2001; 13(8): 1013 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kambayashi, E. Assarsson, J. Michaelsson, P. Berglund, A. D. Diehl, B. J. Chambers, and H.-G. Ljunggren Emergence of CD8+ T Cells Expressing NK Cell Receptors in Influenza A Virus-Infected Mice J. Immunol., November 1, 2000; 165(9): 4964 - 4969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Assarsson, T. Kambayashi, J. K. Sandberg, S. Hong, M. Taniguchi, L. Van Kaer, H.-G. Ljunggren, and B. J. Chambers CD8+ T Cells Rapidly Acquire NK1.1 and NK Cell-Associated Molecules Upon Stimulation In Vitro and In Vivo J. Immunol., October 1, 2000; 165(7): 3673 - 3679. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Marks-Konczalik, S. Dubois, J. M. Losi, H. Sabzevari, N. Yamada, L. Feigenbaum, T. A. Waldmann, and Y. Tagaya IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice PNAS, September 29, 2000; (2000) 200363097. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Kleindienst, I. Chretien, T. Winkler, and T. Brocker Functional comparison of thymic B cells and dendritic cells in vivo Blood, April 15, 2000; 95(8): 2610 - 2616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Hartmann, R. D. Weeratna, Z. K. Ballas, P. Payette, S. Blackwell, I. Suparto, W. L. Rasmussen, M. Waldschmidt, D. Sajuthi, R. H. Purcell, et al. Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo J. Immunol., February 1, 2000; 164(3): 1617 - 1624. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lindberg, A. Martin-Fontecha, and P. Hoglund Natural killing of MHC class I– lymphoblasts by NK cells from long-term bone marrow culture requires effector cell expression of Ly49 receptors Int. Immunol., August 1, 1999; 11(8): 1239 - 1246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-I. Hagiwara, M. Takeya, H. Suzuki, T. Kodama, L. J. W. van der Laan, G. Kraal, N. Kitamura, and K. Takahashi Role of Macrophage Scavenger Receptors in Hepatic Granuloma Formation in Mice Am. J. Pathol., March 1, 1999; 154(3): 705 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Yao, C. Sgadari, K. Furuke, E. T. Bloom, J. Teruya-Feldstein, and G. Tosato Contribution of Natural Killer Cells to Inhibition of Angiogenesis by Interleukin-12 Blood, March 1, 1999; 93(5): 1612 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-J. Lin, N. Hirji, O. Nohara, G. R. Stenton, M. Gilchrist, and A. D. Befus Mast Cells Express Novel CD8 Molecules That Selectively Modulate Mediator Secretion J. Immunol., December 1, 1998; 161(11): 6265 - 6272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Bradley, P. Das, M. M. Griffiths, H. S. Luthra, and C. S. David HLA-DQ6/8 Double Transgenic Mice Develop Auricular Chondritis Following Type II Collagen Immunization: A Model for Human Relapsing Polychondritis J. Immunol., November 1, 1998; 161(9): 5046 - 5053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Lai, N. Alaverdi, L. Maltais, and H. C. Morse III Mouse Cell Surface Antigens: Nomenclature and Immunophenotyping J. Immunol., April 15, 1998; 160(8): 3861 - 3868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Marks-Konczalik, S. Dubois, J. M. Losi, H. Sabzevari, N. Yamada, L. Feigenbaum, T. A. Waldmann, and Y. Tagaya IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice PNAS, October 10, 2000; 97(21): 11445 - 11450. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
